NVO
Novo Nordisk A/S Sponsored ADR Class B · BX:NVO
32.29 CHF0.003000 +0.01%
1-year price target
40.94 CHF
+26.78% from the last price (32.29)
High55.23
Median34.62
Low32.98
Analyst ratings
Based on 6 analysts.
Strong buy1
Buy0
Hold3
Sell2
Strong sell0
Estimates
| Last quarter | Estimate | Next quarter | Next year | |
|---|---|---|---|---|
| EPS (USD) | 0.9551 | 0.7697 | 0.7311 | 3.46 |
| Revenue (USD) | 12.13 B | 10.89 B | 11.08 B | 47.34 B |
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.